Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)

China flag China · Delayed Price · Currency is CNY
11.05
+0.02 (0.18%)
May 13, 2025, 2:45 PM CST
7.80%
Market Cap 14.70B
Revenue (ttm) 5.28B
Net Income (ttm) 648.29M
Shares Out 1.47B
EPS (ttm) 0.44
PE Ratio 24.97
Forward PE 22.06
Dividend 0.25 (2.27%)
Ex-Dividend Date n/a
Volume 3,265,401
Average Volume 3,905,959
Open 11.06
Previous Close 11.03
Day's Range 10.97 - 11.12
52-Week Range 8.10 - 12.54
Beta 0.43
RSI 53.73
Earnings Date Aug 29, 2025

About SHE:002399

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, and internationally. It operates through four segments: Finished Dose Pharmaceutical Products, Active Pharmaceutical Ingredients (API), Contract Development and Manufacturing Organization, and Others. The company’s pharmaceutical products consist of finished dose pharmaceutical products, which primarily include enoxaparin sodium injection; API products, including heparin sodium ... [Read more]

Sector Healthcare
Founded 1998
Employees 1,926
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002399
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.